Literature DB >> 24139857

A haploinsufficiency of FOXG1 identified in a boy with congenital variant of Rett syndrome.

Akira Kumakura1, Satoru Takahashi2, Kazuki Okajima2, Daisuke Hata3.   

Abstract

BACKGROUND: Forkhead box G1 gene (FOXG1) mutations and deletions are associated with a congenital variant of Rett syndrome (RTT). Nucleotide alterations of the coding region of FOXG1 have never caused dysmorphic features. PATIENT: An 8-year-old boy with the congenital variant of RTT who showed severe psychomotor deterioration, epilepsy, acquired microcephaly, and involuntary movements including jerky movements of the upper limbs and tongue protrusion. He showed dysmorphic features including round face, anteverted nostrils, and tented upper lips. Brain magnetic resonance imaging showed hypoplasia of the frontal lobes and the rostral part of the corpus callosum. The molecular cytogenetic analysis confirmed a de novo deletion of 14q12 including FOXG1 in this patient.
CONCLUSION: We identified the smallest deletion of 14q12 involving FOXG1 among those previously reported. Dysmorphic facial features are a characteristic for the patients with chromosomal deletion including FOXG1. In our patient, C14orf23 is the only transcript other than FOXG1. Therefore, C14orf23 might be responsible for facial dysmorphism.
Copyright © 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C14orf23; Congenital variant; Dismorphic facial features; FOXG1; Rett syndrome

Mesh:

Substances:

Year:  2013        PMID: 24139857     DOI: 10.1016/j.braindev.2013.09.006

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  7 in total

Review 1.  Brief report: systematic review of Rett syndrome in males.

Authors:  Brian Reichow; Annie George-Puskar; Tara Lutz; Isaac C Smith; Fred R Volkmar
Journal:  J Autism Dev Disord       Date:  2015-10

2.  Phenotype Differentiation of FOXG1 and MECP2 Disorders: A New Method for Characterization of Developmental Encephalopathies.

Authors:  Mandy Ma; Heather R Adams; Laurie E Seltzer; William B Dobyns; Alex R Paciorkowski
Journal:  J Pediatr       Date:  2016-09-15       Impact factor: 4.406

3.  A New Approach to Rare Diseases of Children: The Undiagnosed Diseases Network.

Authors:  Chloe M Reuter; Elise Brimble; Colette DeFilippo; Annika M Dries; Gregory M Enns; Euan A Ashley; Jonathan A Bernstein; Paul Graham Fisher; Matthew T Wheeler
Journal:  J Pediatr       Date:  2018-01-11       Impact factor: 4.406

4.  Epilepsy and outcome in FOXG1-related disorders.

Authors:  Laurie E Seltzer; Mandy Ma; Sohnee Ahmed; Mary Bertrand; William B Dobyns; James Wheless; Alex R Paciorkowski
Journal:  Epilepsia       Date:  2014-05-16       Impact factor: 5.864

5.  FOXG1 syndrome: genotype-phenotype association in 83 patients with FOXG1 variants.

Authors:  Diana Mitter; Milka Pringsheim; Marc Kaulisch; Kim Sarah Plümacher; Simone Schröder; Rita Warthemann; Rami Abou Jamra; Martina Baethmann; Thomas Bast; Hans-Martin Büttel; Julie S Cohen; Elizabeth Conover; Carolina Courage; Angelika Eger; Ali Fatemi; Theresa A Grebe; Natalie S Hauser; Wolfram Heinritz; Katherine L Helbig; Marion Heruth; Dagmar Huhle; Karen Höft; Stephanie Karch; Gerhard Kluger; G Christoph Korenke; Johannes R Lemke; Richard E Lutz; Steffi Patzer; Isabelle Prehl; Konstanze Hoertnagel; Keri Ramsey; Tina Rating; Angelika Rieß; Luis Rohena; Mareike Schimmel; Rachel Westman; Frank-Martin Zech; Barbara Zoll; Dörthe Malzahn; Birgit Zirn; Knut Brockmann
Journal:  Genet Med       Date:  2017-06-29       Impact factor: 8.822

6.  Partial monosomy14q involving FOXG1 and NOVA1 in an infant with microcephaly, seizures and severe developmental delay.

Authors:  H Fryssira; E Tsoutsou; S Psoni; S Amenta; T Liehr; E Anastasakis; Ch Skentou; A Ntouflia; I Papoulidis; E Manolakos; N Chaliasos
Journal:  Mol Cytogenet       Date:  2016-08-02       Impact factor: 2.009

7.  The FOXG1/FOXO/SMAD network balances proliferation and differentiation of cortical progenitors and activates Kcnh3 expression in mature neurons.

Authors:  Riccardo Vezzali; Stefan Christopher Weise; Nicole Hellbach; Venissa Machado; Stefanie Heidrich; Tanja Vogel
Journal:  Oncotarget       Date:  2016-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.